Multiple Arterial Revascularization versus Single in a patients with coronary artery disease

Not Applicable

Recruiting

• Conditions: Coronary artery bypass grafting patency; Coronary heart disease; Surgery - Surgical techniques; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12622000552785
• Lead Sponsor: Ministry of Science and Higher Education

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-08
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

coronary artery disease

Exclusion Criteria

Concomitant surgery (valve surgery, aorta surgery)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major adverse cardiac events (MACE) (which are death from any cause, myocardial infarction [MI], or unplanned revascularization for ischemia). This outcome is assessed by data-linkage to medical records.[Death from any cause, myocardial infarction [MI], or unplanned revascularization for ischemia are assessed for 30 days post-surgery.];Coronary flow reserve on Single photon emission computed tomography (SPECT)[Assessed once at 30 days post-surgery]

Secondary Outcome Measures

Name	Time	Method
Major adverse cardiac events(MACE) (which are death from any cause, myocardial infarction [MI], or unplanned revascularization for ischemia). This outcome is assessed by data-linkage to medical records.[at 1 and 5 year after operation]